Leukopheresis for profound hyperleukocytosis

Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH. Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25(3): 83–177 Bug, 2007, Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis, Transfusion, 47, 1843, 10.1111/j.1537-2995.2007.01406.x Rowe, 1984, Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia, Blood, 63, 1230, 10.1182/blood.V63.5.1230.1230 Blum W, Porcu P. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost. 2007; 33(4): 350–354. Bandarenko N, Lockhart E. Therapeutic leukocyte and platelet depletion. In: McLeod BC, Szczepiorkowski ZM, Weinstein R, Winters JL, eds. Aphersis: Principles and Practice, 3rd Ed. Bethesda, MD: AABB Press, 2010. Yetter EM, Acosstal, KB, Olson MC, Blundell K. Estimating splenic volume: sonographic measurements correlated with helical CT determination. Am J Roentgenol 2003: 181:1615–1620. Shafique, 2007, A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis, Ther Apher Dial, 11, 146, 10.1111/j.1744-9987.2007.00417.x Lichtman MA. Rheology of leukocytes, leukocyte suspensions and blood in leukemia. J Clin Invest 1973; 52: 350–358. Ting-Beall HP, Needham D, Hochmuth RM. Volume and osmotic properties of human neutrophils. Blood 1993; 81: 2774–2780.